Literature DB >> 7535570

Alterations in L-selectin expression and elastase activity in neutrophils from patients receiving granulocyte colony-stimulating factor alone or in conjunction with high-dose chemotherapy with autologous bone marrow transplantation.

K M Rao1, M S Currie, H J Cohen, W P Peters.   

Abstract

We determined L-selectin expression and elastase levels in neutrophils obtained from patients receiving granulocyte colony-stimulating factor (G-CSF) either alone (given for increasing peripheral progenitor cells for harvest) or in combination with high-dose chemotherapy with autologous bone transplantation support (BMT). Administration of G-CSF alone for 3-5 days produced a decrease in L-selectin expression in neutrophils (25 +/- 4 versus 7 +/- 1, mean +/- SEM; mean channel fluorescence, n = 10) with no effect on neutrophil elastase activity (3.1 +/- 0.3 versus 3.4 +/- 0.6; micrograms elastase/million cells; n = 9). In contrast, in patients in the BMT group the L-selectin expression was increased (26 +/- 2 versus 38 +/- 3; n = 20) and elastase activity was markedly decreased (2.9 +/- 0.2 versus 1.4 +/- 0.2, n = 12) compared with values before BMT. The changes in L-selectin expression correlated with the ability of neutrophils to adhere to human umbilical vein endothelial cells. The decrease in the neutrophil elastase activity was not associated with an increase in the plasma elastase/alpha 1-antitrypsin complex levels, indicating that the decrease in the neutrophil elastase activity is not caused by activation of neutrophils and release of the enzyme into the plasma. Administration of G-CSF alone did not cause a decrease in the neutrophil elastase activity but increased plasma elastase/alpha 1-antitrypsin complex levels. There was no change in CR3 expression on neutrophils under any of these conditions. These observations suggest that the changes seen in neutrophils during BMT are influenced by various factors associated with BMT other than the administered cytokine alone.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7535570

Source DB:  PubMed          Journal:  Lymphokine Cytokine Res        ISSN: 1056-5477


  2 in total

1.  No evidence for cell activation or brain vaso-occlusion with plerixafor mobilization in sickle cell mice.

Authors:  Erika Choi; Craig Branch; Min-Hui Cui; Karina Yazdanbakhsh; Narla Mohandas; Henny H Billett; Patricia A Shi
Journal:  Blood Cells Mol Dis       Date:  2015-12-21       Impact factor: 3.039

2.  Paradoxical drop in circulating neutrophil count following granulocyte-colony stimulating factor and stem cell factor administration in rhesus macaques.

Authors:  Brent C Gordon; Amy M Revenis; Aylin C Bonifacino; William E Sander; Mark E Metzger; Allen E Krouse; Tatiana N Usherson; Robert E Donahue
Journal:  Exp Hematol       Date:  2007-06       Impact factor: 3.084

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.